Results 101 to 110 of about 26,891 (150)

Ischemia-Modified Albumin (IMA) Is Associated with Poor Survival in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF): A Pilot Study. [PDF]

open access: yesAntioxidants (Basel)
Zinellu A   +12 more
europepmc   +1 more source

Ischemia Modified Albumin –An Early Marker of Myocardial Ischemia

open access: yesJournal of Medical Science And clinical Research, 2016
openaire   +1 more source

The role of ischemia-modified albumin, presepsin, delta neutrophil index, and inflammatory markers in diagnosing acute cholecystitis. [PDF]

open access: yesUlus Travma Acil Cerrahi Derg
Gedik MS   +7 more
europepmc   +1 more source

Ischemia modified albumin in perinatology

European Journal of Obstetrics, Gynecology and Reproductive Biology, 2017
Ischemia modified albumin is a novel marker of ischemia generated due to hypooxygenation and increased hydroxyl free radicals in low pH. The molecule has been licenced for clinical use as an early marker for acute coronary syndrome in cardiology. Since presence of ischemia might have serious and sometimes devastating effects in perinatology, various ...
Asli Yarci Gursoy, Gamze Sinem Caglar
exaly   +3 more sources

Standardization of ischemia-modified albumin testing: adjustment for serum albumin

Clinical Chemistry and Laboratory Medicine, 2007
The diagnostic approach to acute myocardial infarction (AMI) is still one of the most challenging and controversial medical issues. Although the measurement of cardiospecific troponins has emerged as the gold standard for management of patients with acute chest pain, it is often unsuitable for early diagnosis, as nearly 50% of patients may present with
Giuseppe Lippi   +2 more
exaly   +5 more sources

The novel ischemia marker ‘ischemia‐modified albumin’ is increased in normal pregnancies

Acta Obstetricia Et Gynecologica Scandinavica, 2009
AbstractThe aim of this prospective case‐control study was to determine the change in serum maternal ischemia‐modified albumin (IMA) during normal pregnancies. A total of 117 pregnant (first trimester (n = 24), second trimester (n = 34), and third trimester (n = 35)) and non‐pregnant healthy women (n = 23) were included.
Suleyman Güven   +2 more
exaly   +6 more sources

Ischemia-Modified Albumin in Gynecology

Biomarkers in Medicine, 2021
Background: Ischemia-modified albumin (IMA) is an oxidative stress marker used to assess the presence and severity of oxidative stress. This marker was first used for early diagnosis of myocardial ischemia. Materials & methods: A variety of IMA studies were carried out to show the effect of oxidative stress on gynecological disorders.
Mehmet F Kıncı   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy